Literature DB >> 6088134

Evidence of cells bearing interleukin-2 receptor at sites of disease activity in sarcoid patients.

G Semenzato, C Agostini, L Trentin, R Zambello, M Chilosi, A Cipriani, E Ossi, M R Angi, L Morittu, G Pizzolo.   

Abstract

The frequency of cells reactive with anti-Tac monoclonal antibody (MoAb), which recognizes the interleukin-2 (IL-2) receptor, has been evaluated in cell suspensions from peripheral blood and bronchoalveolar lavage (BAL), and in frozen sections from involved tissues in 18 patients with active sarcoidosis. Peripheral blood lymphocytes of sarcoid patients do not bear Tac determinant and reduced numbers of Tac+ cells are inducible following PHA stimulation. On the other hand, significant numbers of lymphocytes reactive with anti-TacMoAb are present in the cells obtained from the BAL and a number of Tac+ cells infiltrate the lung, lymph node and conjunctiva. The finding of Tac+ cells in the BAL fluid and in other organs in patients with sarcoidosis provides evidence that some T cells in these involved tissues have the characteristics of IL-2 responder cells and thus the potential to absorb IL-2, supporting the hypothesis that T lymphocytes replicate in situ at sites of disease activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088134      PMCID: PMC1536107     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  24 in total

1.  Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins.

Authors:  N R Ling; S Bishop
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

2.  Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation.

Authors:  S Gillis; G R Crabtree; K A Smith
Journal:  J Immunol       Date:  1979-10       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  Redistribution of T lymphocytes in the lymph nodes of patients with sarcoidosis.

Authors:  G Semenzato; A Pezzutto; M Chilosi; G Pizzolo
Journal:  N Engl J Med       Date:  1982-01-07       Impact factor: 91.245

5.  Immunoregulation in sarcoidosis.

Authors:  G Semenzato; A Pezzutto; C Agostini; G Gasparotto; A Cipriani
Journal:  Clin Immunol Immunopathol       Date:  1981-06

6.  Flow cytometry analysis of T lymphocytes in sarcoidosis.

Authors:  Y Pacheco; G Cordier; M Perrin-Fayolle; J P Revillard
Journal:  Am J Med       Date:  1982-07       Impact factor: 4.965

7.  Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity.

Authors:  G W Hunninghake; R G Crystal
Journal:  N Engl J Med       Date:  1981-08-20       Impact factor: 91.245

8.  Surface phenotype of Japanese adult T-cell leukemia cells characterized by monoclonal antibodies.

Authors:  T Hattori; T Uchiyama; T Toibana; K Takatsuki; H Uchino
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

9.  T cell growth factor receptors. Quantitation, specificity, and biological relevance.

Authors:  R J Robb; A Munck; K A Smith
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

10.  Lyt-23+ cyclophosphamide-sensitive T cells regulate the activity of an interleukin 2 inhibitor in vivo.

Authors:  C Hardt; M Röllinghoff; K Pfizenmaier; H Mosmann; H Wagner
Journal:  J Exp Med       Date:  1981-08-01       Impact factor: 14.307

View more
  16 in total

1.  Th1 cytokine pattern in sarcoidosis is expressed by bronchoalveolar CD4+ and CD8+ T cells.

Authors:  A Prasse; C G Georges; H Biller; H Hamm; H Matthys; W Luttmann; J C Virchow
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

2.  Biological role of the soluble interleukin-2 receptor in sarcoidosis.

Authors:  Remi M M Vanmaris; Ger T Rijkers
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

3.  Evidence for enhanced interleukin 2 (IL-2) secretion and IL-2 receptor presentation by synovial fluid lymphocytes in rheumatoid arthritis.

Authors:  G Lemm; H Warnatz
Journal:  Clin Exp Immunol       Date:  1986-04       Impact factor: 4.330

4.  Limited heterogeneity of biased T-cell receptor V beta gene usage in lung but not blood T cells in active pulmonary sarcoidosis.

Authors:  R F Silver; R G Crystal; D R Moller
Journal:  Immunology       Date:  1996-08       Impact factor: 7.397

5.  Expression of thioredoxin in granulomas of sarcoidosis: possible role in the development of T lymphocyte activation.

Authors:  T Koura; Y Gon; S Hashimoto; A Azuma; S Kudoh; Y Fukuda; I Sugawara; J Yodoi; T Horie
Journal:  Thorax       Date:  2000-09       Impact factor: 9.139

Review 6.  Cells and molecules involved in the development of sarcoid granuloma.

Authors:  C Agostini; U Basso; G Semenzato
Journal:  J Clin Immunol       Date:  1998-05       Impact factor: 8.317

Review 7.  Obstructive sarcoidosis.

Authors:  Petey Laohaburanakit; Andrew Chan
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

8.  Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.

Authors:  K Konishi; D R Moller; C Saltini; M Kirby; R G Crystal
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

9.  Immunohistochemical analysis of sarcoid granulomas. Evaluation of Ki67+ and interleukin-1+ cells.

Authors:  M Chilosi; F Menestrina; P Capelli; L Montagna; M Lestani; G Pizzolo; A Cipriani; C Agostini; L Trentin; R Zambello
Journal:  Am J Pathol       Date:  1988-05       Impact factor: 4.307

10.  Clonal analysis of lung and blood T cells in patients with sarcoidosis.

Authors:  M J Garlepp; A H Rose; J E Dench; B W Robinson
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.